Prognos

Home New

New York, United States · $65.5M raised

Headquarters
New York, New York
Total Funding
$65.5M
Last Round
$23.0M Growth EquityMay 2023
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 6 investors for this company. The full record is or through the API.

About

Prognos Health was founded in 2010 as Medivo by Sundeep Bhan, Jason Bhan, and Destry Sulkes, and relaunched under the Prognos name in January 2017 after six years building clinical diagnostic analytics. The New York-based company maintains a lab-data registry it says covers more than 325 million patients drawn from 20-plus laboratory sources, with 215 million patients usable for commercial analytics when linked with medical claims. Named offerings include the Prognos Factor health data marketplace plus packaged solutions for oncology, rare disease, commercial analytics, and precision marketing, sold mainly to life-sciences commercial and medical-affairs teams and to payers. Early registry collaborators included LabCorp, Quest Diagnostics, Biogen, and Cigna.

Summary

Prognos is an Analytics company based in New York, United States. It has raised $65.5M in total across 4 rounds, most recently a $23.0M Growth Equity round in May 2023. Investors include Safeguard Scientifics, Merck Global Health Innovation Fund and Marshall Wace.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Growth EquityGrowth EquityMay 2023
$23.0M

Sign up to see all 4 events

Funding: Series A through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Prognos on Indexed.vc
<a href="https://indexed.vc/companies/prognos"><img src="https://indexed.vc/api/badge/company/prognos" alt="Prognos on Indexed.vc" width="260" height="76" /></a>